BRIEF published on 03/26/2026 at 07:34, 27 days 7 hours ago DEUTZ Reports Robust Growth Amid Challenging Market Conditions in 2025 Revenue Growth Strategic Transformation DEUTZ AG Cost-cutting Program Annual Results 2025
BRIEF published on 03/26/2026 at 07:34, 27 days 7 hours ago DEUTZ prévoit une forte croissance malgré un contexte de marché difficile en 2025 Croissance Des Revenus Transformation Stratégique DEUTZ AG Programme De Réduction Des Coûts Résultats Annuels 2025
BRIEF published on 03/26/2026 at 07:32, 27 days 7 hours ago Delivery Hero's Adj. EBITDA Rises by 30% Amid Strategic Adjustments Free Cash Flow EBITDA Growth Quick Commerce Taiwan Asset Sale Everyday App Strategy
BRIEF published on 03/26/2026 at 07:32, 27 days 7 hours ago L'EBITDA ajusté de Delivery Hero progresse de 30 % grâce à des ajustements stratégiques. Flux De Trésorerie Disponible Croissance De L'EBITDA Commerce Rapide Vente D'actifs Taïwanais Stratégie D'application Quotidienne
BRIEF published on 03/26/2026 at 07:16, 27 days 7 hours ago Berentzen-Gruppe Reports 2025 Results with Significant Profit Dividend Proposal Berentzen Group Profit Report 2026 Outlook 2025 Financial Results
BRIEF published on 03/26/2026 at 07:16, 27 days 7 hours ago Berentzen-Gruppe annonce des résultats 2025 avec un bénéfice significatif Proposition De Dividende Groupe Berentzen Rapport Sur Les Bénéfices Résultats Financiers 2025 Perspectives 2026
BRIEF published on 03/26/2026 at 07:12, 27 days 7 hours ago Heidelberg Pharma Publishes 2025 Financial Results and 2026 Outlook Financial Results Cost-cutting Measures Heidelberg Pharma ADC Technology 2026 Outlook
BRIEF published on 03/26/2026 at 07:12, 27 days 7 hours ago Heidelberg Pharma publie ses résultats financiers pour 2025 et ses perspectives pour 2026. Résultats Financiers Heidelberg Pharma Mesures De Réduction Des Coûts Technologie ADC Perspectives 2026
BRIEF published on 03/26/2026 at 07:10, 27 days 7 hours ago Swissmedic Approves PEDMARQSI® for Preventing Hearing Loss in Children Swissmedic Approval Norgine PEDMARQSI® Children's Hearing Loss Cisplatin Chemotherapy
BRIEF published on 03/26/2026 at 07:10, 27 days 7 hours ago Swissmedic approuve PEDMARQSI® pour la prévention de la perte auditive chez l'enfant Norgine PEDMARQSI® Approbation Swissmedic Perte Auditive Chez L'enfant Chimiothérapie Au Cisplatine
Published on 04/22/2026 at 13:45, 1 hour 13 minutes ago Amarc Announces Listing on Frankfurt Stock Exchange
Published on 04/22/2026 at 13:30, 1 hour 28 minutes ago ZTEST Electronics Inc. Announces Its Intention to Effect a Normal Course Issuer Bid
Published on 04/22/2026 at 13:30, 1 hour 28 minutes ago Copper Road Announces Engagement of George Mannard
Published on 04/22/2026 at 13:00, 1 hour 58 minutes ago AmeriTrust Announces 2025 Annual Financial Results
Published on 04/22/2026 at 13:00, 1 hour 58 minutes ago Kalo Gold Defines Kilometre-Scale Epithermal Gold Targets and Structural Corridors at Wainikoro Within a 40 km Gold Corridor, Vatu Aurum, Fiji
Published on 04/22/2026 at 14:41, 17 minutes ago Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc
Published on 04/22/2026 at 14:39, 19 minutes ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property PLC
Published on 04/22/2026 at 07:00, 7 hours 58 minutes ago Chiffre d'affaires 1er trimestre 2026. 229,5M€ à devises constantes. 215,5 M€ à devises courantes.
Published on 04/22/2026 at 07:00, 7 hours 58 minutes ago Q1 2026 sales. €229.5m at constant exchange rates. €215.5m at current exchanges rates
Published on 04/21/2026 at 19:15, 19 hours 43 minutes ago AXA - Description of the Company’s share repurchase program
